SWISS-KOREAN LIFE SCIENCE INITIATIVE

The Swiss-Korean Life Science Initiative is a public-private platform to nurture interdisciplinary collaboration between medical doctors, scientists, engineers, start-ups and the private industry.

Annually, a Swiss-Korean Life Science Symposium is organized to network and discuss common projects.

Main supporters of the Initiative are the following:

  • Swiss State Secretariat for Education, Research and Innovation (SERI)
  • Korean Ministry of Health and Welfare
  • University of Basel/University Hospital Basel
  • Swiss Tropical and Public Health Institute
  • ETH Zurich
  • EPFL
  • Yonsei University/Severance Hospital
  • Novartis
  • Roche
  • Roche Diagnostics
  • MedTech Innovation Partners AG

Life Science Symposium 2015

The 2nd Swiss-Korean Life Science Symposium took place from 22nd-23rd of October 2015. The event was co-organized by the Embassy of Switzerland’s Science and Technology Office and Korea Health Industry Development Institute (KHIDI). The Symposium was sponsored by Korean Ministry of Health and Welfare (MOHW) and the Swiss State Secretariat for Education, Research and Innovation (SERI) from government as well as Novartis, Roche, Roche Diagnostics and MedTech Innovation Partners (MTIP).

The main areas of the Symposium were:

  • Life Science R&D Ecosystem
  • Biomedical Technologies in Korea
  • Global Health – Neglected Disease & Drug Development
  • Medical Technology/Medtech Start-Ups

From Switzerland, a total of 26 participants took part in the Symposium from the University of Basel, Swiss TPH, ETH Zurich, the University Hospital Basel and Canton of Basel representatives. In addition, 4 start-ups and representatives from Roche and Novartis took part. Vice-Rector Edwin Constable from Uni Basel was the delegation leader from Switzerland.

On the Korean side, KHIDI actively supported the Embassy to recruit speakers from various government sectors, top-notch researchers and industry partners. The Korean speakers were mostly of very high level and consisted of:

  • Professors, researchers and physicians from Korea’s main institutions (Korea Institute for Science & Technology, Seoul National University, Severance Hospital, Ulsan National Institute of Science and Technology, Korea Institute of Science and Technology, Korea University, Chonnam University )
  • Korean government institutions (KHIDI, Osong Biomedical Innovation Foundation, Ministry of Food and Drug Safety, Korea National Institute of Health, Korea Intellectual Property Office).
  • International organizations based in Korea (Institute Pasteur – Korea and International Vaccine Institute)
  • Korean private sector (Korean Venture Capital firms, Yozma Group, Green Cross, Crystal Genomics, GeneOne Life Science, Qurient, Kim & Chang Law Firm, 4 start-ups)

The second Life Science Symposium once again demonstrated the significance of collaboration between Swiss and Korean innovators, researchers and sciencetists from both public and private actors. The continuation fo this collaboration will carry on to the third Life Science Symposium in year 2016. Along with the third symposium, smaller targetted meetings/workshops will be also added.

Life Science Symposium 2014

The 1st Swiss-Korean Life Science Symposium took place from 7th-8th of May 2014. The event was co-organized by the Embassy of Switzerland’s Science and Technology Office and Korea Research Institute of Bioscience and Biotechnology (KRIBB). The Symposium was sponsored by Swiss (SERI) and Korean (Ministry of Science, ICT and Future Planning) counterparts.

The main areas of the Symposium were:

  • Life Science R&D Policy in Switzerland and Korea
  • Global Health and R&D
  • Biotechnology (Nano and Bioinformatics)
  • Personalized Health (Stem Cells and Genetics)

From Switzerland, a total of 13 participants took part in the Symposium from the University of Basel, Swiss TPH, Friedrich Miescher Institute, the University Hospital Basel and Novartis/Novartis Institute of Biomedical Research Shanghai.

From Korea, professors, researchers and medical doctors from Korea Institute of Science & Technology, Seoul National University Hospital, Severance Hospital, Catholic University, Hanyang University, Dongguk University participated along with Korean government institutes (Presidential Advisory Council for Science and Technology, National Institute of Health, Korea Institute for Industrial Economics and Trade), international organization (Institute Paseur – Korea and International Vaccine Institute), and Korean private sectors (Bioneer, Viromed, and Samsung BioLogics). Click here for more information on participants.

The first Life Science Symposium strengthened and emphasized the importance of increasing activities between Swiss and Korean partners in life science. Second edition of the Symposium was uniformly requested.